MedTrace Logo

ERAS for Patients Received Neoadjuvant Chemotherapy

NCT03272984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2017-09-08

No results posted yet for this study

Summary

Patients received neoadjuvant chemotherapy with locally advanced gastric caner undergo the enhanced recovery after surgery (ERAS) programs or the standard cares (SC) programs.

Conditions

Interventions

PROCEDURE

ERAS group

ERAS is the name of a procedure. Patients in this group need receive the ERAS procedure instead of one drug.

PROCEDURE

SC group

Patients were managed in accordance with SC programs during the perioperative period. SC programs were used daily in our center and were still routinely used in most of the other hospitals in China.

Sponsors & Collaborators

  • JIANG Zhi-Wei

    lead OTHER

Principal Investigators

  • Zhiwei JIANG, MD · Jinling Hospital, Medical School of Nanjing University

  • Jian ZHAO, MD · Jinling Hospital, Medical School of Nanjing University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2017-06-05
Completion
2017-07-06

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03272984 on ClinicalTrials.gov